Medicines | European Medicines Agency

Medicines

For help on how to get the results you want, see our search tips.

Search results

Categories

Medicine name

Active substance / international non-proprietary name (INN) / common name

Medicine

Referral name

Referral status

Referral safety status

Referral type

Referral reference number

Referral authorisation model

Date of opinion

Decision date

Related medicine

Last updated

First published

240 results

Sort by

List item

Referral: Cozaar Comp

losartan + hydrochlorothiazide, Article 30 referrals
Status: European Commission final decision, opinion/position date: 24/04/2008, EC decision date: 03/09/2008, Last updated: 25/09/2008
List item

Referral: Actilyse

Alteplase, Article 29(4) referrals
Status: European Commission final decision, opinion/position date: 27/06/2002, EC decision date: 30/09/2002, Last updated: 25/01/2006
List item

Referral: Actira

moxifloxacin, Article 6(12) referrals (prior to January 2010)
Status: European Commission final decision, opinion/position date: 20/03/2008, EC decision date: 14/07/2008, Last updated: 13/10/2008
List item

Referral: Adartrel

Ropinirole, Article 29(4) referrals
Status: European Commission final decision, opinion/position date: 15/09/2005, EC decision date: 03/04/2006, Last updated: 21/04/2006
List item

Referral: Aggrastat

Tirofiban, Article 29(4) referrals
Status: European Commission final decision, opinion/position date: 26/03/1999, EC decision date: 18/06/1999, Last updated: 18/06/1999
List item

Referral: Agopton

Lansoprazole, Article 30 referrals
Status: European Commission final decision, opinion/position date: 21/09/2006, EC decision date: 13/12/2006, Last updated: 20/12/2006
List item

Referral: Alcover and associated names

sodium oxybate, associated names: n/a, Article 29(4) referrals
Status: European Commission final decision, opinion/position date: 26/01/2017, EC decision date: 18/12/2017, Last updated: 12/01/2018
List item

Referral: Alendronate HEXAL

alendronic acid (as sodium alendronate trihydrate), Article 29(4) referrals
Status: European Commission final decision, opinion/position date: 25/01/2007, EC decision date: 13/04/2007, Last updated: 20/08/2007
List item

Referral: Alvesco

ciclesonide, Article 29(4) referrals
Status: European Commission final decision, opinion/position date: 20/03/2008, EC decision date: 11/07/2008, Last updated: 05/08/2008
List item

Referral: Amaryl

Glimepiride, Article 29(4) referrals
Status: European Commission final decision, opinion/position date: 17/04/1996, EC decision date: 29/08/1996, Last updated: 03/08/1998
List item

Referral: Amlodipin Woerwag

Amlodipine, Article 29(4) referrals
Status: European Commission final decision, opinion/position date: 21/01/2004, EC decision date: 27/04/2004, Last updated: 30/06/2004
List item

Referral: Amlovita

Amlodipine, Article 29(4) referrals
Status: European Commission final decision, opinion/position date: 21/01/2004, EC decision date: 26/04/2004, Last updated: 26/04/2004
List item

Referral: Amoxil

amoxicillin, Article 30 referrals
Status: European Commission final decision, opinion/position date: 25/06/2015, EC decision date: 20/08/2015, Last updated: 19/05/2016
List item

Referral: Arcoxia

etoricoxib, Article 6(12) referrals (prior to January 2010)
Status: European Commission final decision, opinion/position date: 26/06/2008, EC decision date: 09/09/2008, Last updated: 21/11/2008
List item

Referral: Arimidex

anastrozole, Article 30 referrals
Status: European Commission final decision, opinion/position date: 17/03/2011, EC decision date: 18/05/2011, Last updated: 27/07/2011
List item

Referral: Atacand

candesartan, associated names: Amias, Blopress, Kenzen, Racanda, Ratacand, Parapres, Article 30 referrals
Status: European Commission final decision, opinion/position date: 18/03/2010, EC decision date: 13/07/2010, Last updated: 16/03/2011
List item

Referral: Atacand Plus

candesartan / hydrochlorothiazide, associated names: Atacand Zid, Blopresid, Blopress Comp, Blopress Plus, CoKenzen, Hytacand, Parapres Plus, Ratacand Plus, Article 30 referrals
Status: European Commission final decision, opinion/position date: 24/06/2010, EC decision date: 16/09/2010, Last updated: 21/09/2011
List item

Referral: Augmentin

amoxicillin and clavulanic acid, Article 30 referrals
Status: European Commission final decision, opinion/position date: 19/01/2009, EC decision date: 19/10/2009, Last updated: 18/11/2013
List item

Referral: Avalox

moxifloxacin, Article 29(4) referrals
Status: European Commission final decision, opinion/position date: 25/06/2009, EC decision date: 02/10/2009, Last updated: 19/11/2013
List item

Referral: Avelox

moxifloxacin, Article 6(12) referrals (prior to January 2010)
Status: European Commission final decision, opinion/position date: 20/03/2008, EC decision date: 14/07/2008, Last updated: 13/10/2008
List item

Referral: Betavert N

betahistine dihydrochloride, Article 29(4) referrals
Status: European Commission final decision, opinion/position date: 20/03/2009, EC decision date: 02/06/2009, Last updated: 01/07/2007
List item

Referral: Bicaluplex

bicalutamide, Article 29(4) referrals
Status: European Commission final decision, opinion/position date: 20/09/2007, EC decision date: 22/11/2007, Last updated: 07/02/2008
List item

Referral: Bifril, Teoula, Zofepril, Zopranol

zofenopril, Article 6(12) referrals (prior to January 2010)
Status: European Commission final decision, opinion/position date: 27/07/2000, EC decision date: 29/11/2000, Last updated: 29/11/2000
List item

Referral: Bleomycin

bleomycin, Article 29(4) referrals
Status: European Commission final decision, opinion/position date: 19/12/2008, EC decision date: 12/03/2009, Last updated: 31/03/2009
List item

Referral: Budesonide Sandoz

budesonide, Article 29(4) referrals
Status: European Commission final decision, opinion/position date: 20/02/2009, EC decision date: 07/05/2009, Last updated: 25/06/2009